GL1X · GenesisL1 explorer

UniProt Q00960

Glutamate receptor ionotropic, NMDA 2B (Q00960)

Glutamate receptor ionotropic, NMDA 2B (UniProt Q00960): 60 experimental structures on GenesisL1, 14 ligands bound, 104 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
Q00960
Protein
Glutamate receptor ionotropic, NMDA 2B
Experimental structures
60
Predicted models
0
Ligands
14
Pockets
104 · 7 records with a druggable one

Structures

60 records of Q00960 in the MolNFT archive: 60 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
3JPWCrystal structure of amino terminal domain of the NMDA receptor subunit NR2Bx-ray diffractionA——
3JPWCrystal structure of amino terminal domain of the NMDA receptor subunit NR2Bx-ray diffractionA——
3JPYCrystal structure of the zinc-bound amino terminal domain of the NMDA receptor subunit NR2Bx-ray diffractionA——
3JPYCrystal structure of the zinc-bound amino terminal domain of the NMDA receptor subunit NR2Bx-ray diffractionA——
3QELCrystal structure of amino terminal domains of the NMDA receptor subunit GluN1 and GluN2B in…x-ray diffractionB, D——
3QELCrystal structure of amino terminal domains of the NMDA receptor subunit GLUN1 and GLUN2B in…x-ray diffractionB, D——
3QEMCrystal structure of amino terminal domains of the NMDA receptor subunit GluN1 and GluN2B in…x-ray diffractionB, D——
3QEMCrystal structure of amino terminal domains of the NMDA receptor subunit GLUN1 and GLUN2B in…x-ray diffractionB, D——
4PE5Crystal Structure of GluN1a/GluN2B NMDA Receptor Ion Channelx-ray diffractionB, D——
4PE5Crystal structure of GLUN1A/GLUN2B NMDA receptor ion channelx-ray diffractionB, D——
5B3JActivation of NMDA receptors and the mechanism of inhibition by ifenprodilx-ray diffractionC, D——
5B3JActivation of NMDA receptors and the mechanism of inhibition by ifenprodilx-ray diffractionC, D——
5FXGGLUN1B-GLUN2B NMDA receptor in active conformationelectron microscopyB, D——
5FXGGLUN1B-GLUN2B NMDA receptor in active conformationelectron microscopyB, D——
5FXHGluN1b-GluN2B NMDA receptor in non-active-1 conformationelectron microscopyB, D——
5FXHGLUN1B-GLUN2B NMDA receptor in non-active-1 conformationelectron microscopyB, D——
5FXIGluN1b-GluN2B NMDA receptor structure in non-active-2 conformationelectron microscopyB, D——
5FXIGLUN1B-GLUN2B NMDA receptor structure in non-active-2 conformationelectron microscopyB, D——
5FXJGLUN1B-GLUN2B NMDA receptor structure-class Xelectron microscopyB, D——
5FXKGluN1b-GluN2B NMDA receptor structure-Class Yelectron microscopyB, D——
5FXKGLUN1B-GLUN2B NMDA receptor structure-class Yelectron microscopyB, D——
5TPZCrystal structure of amino terminal domains of the NMDA receptor subunit GLUN1 and GLUN2B in apo…x-ray diffractionDNAG—
6CNAGLUN1-GLUN2B NMDA receptors with exon 5electron microscopyB, DNAG—
6E7RHeterodimer of the GLUN1B-GLUN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor…x-ray diffractionB, DCL, NAG, HYS—
6E7SHeterodimer of the GLUN1B-GLUN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor…x-ray diffractionB, DCL, NAG, HZ4—
6E7THeterodimer of the GLUN1B-GLUN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor…x-ray diffractionB, DCL, NAG, HYY—
6E7UHeterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor…x-ray diffractionB, DCL, NAG, HX713 (best 0.77)
6E7UHeterodimer of the GLUN1B-GLUN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor…x-ray diffractionB, DCL, NAG, HX7—
6E7VHeterodimer of the GLUN1B-GLUN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor…x-ray diffractionB, DCL, NAG, T88—
6E7WHeterodimer of the GLUN1B-GLUN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor…x-ray diffractionB, DCL, NAG, HXM—
6E7XHeterodimer of the GLUN1B-GLUN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor…x-ray diffractionB, DCL, NAG, T97—
6WHRGLUN1B-GLUN2B NMDA receptor in non-active 2 conformation at 4 ångström resolutionelectron microscopyB, DNAG—
6WHSGLUN1B-GLUN2B NMDA receptor in non-active 1 conformation at 3.95 ångström resolutionelectron microscopyB, DNAG—
6WHTGLUN1B-GLUN2B NMDA receptor in active conformation at 4.4 ångström resolutionelectron microscopyB, DNAG—
6WHUGLUN1B-GLUN2B NMDA receptor in complex with sdz 220-040 and L689,560, class 1electron microscopyB, DNAG—
6WHVGluN1b-GluN2B NMDA receptor in complex with SDZ 220-040 and L689,560, class 2electron microscopyB, DNAG—
6WHVGLUN1B-GLUN2B NMDA receptor in complex with sdz 220-040 and L689,560, class 2electron microscopyB, DNAG—
6WI0GLUN1B-GLUN2B NMDA receptor in complex with GLUN1 antagonist L689,560, class 2electron microscopyB, DNAG—
7SAAGlycine and glutamate bound GLUN1A-GLUN2B NMDA receptors in non-active 1 conformation at 2.97…electron microscopyB, DNAG—
7SABPhencyclidine-bound GluN1a-GluN2B NMDA receptorselectron microscopyB, DNAG, 1PC—
7SABPhencyclidine-bound GLUN1A-GLUN2B NMDA receptorselectron microscopyB, DNAG, 1PC—
7SACS-(+)-ketamine bound GluN1a-GluN2B NMDA receptors at 3.69 Angstrom resolutionelectron microscopyB, DNAG, GLU, JC915 (best 0.84)
7SACS-(+)-ketamine bound GLUN1A-GLUN2B NMDA receptors at 3.69 ångström resolutionelectron microscopyB, DNAG, JC9—
7SADMemantine-bound GluN1a-GluN2B NMDA receptorselectron microscopyB, DNAG, 377—
7SADMemantine-bound GLUN1A-GLUN2B NMDA receptorselectron microscopyB, DNAG, 377—
7TE6Crystal structure of GLUN1B-2B atd complexed to FAB5 anti-GLUN2B antibodyx-ray diffractionB, F——
7TE9Cryo-EM structure of GLUN1B-2B nmdar complexed to FAB2 CLASS1electron microscopyB, D——
7TEBCryo-EM structure of GLUN1B-2B nmdar complexed to FAB2 non-ACTIVE1- likeelectron microscopyB, D——
7TEECryo-EM structure of GLUN1B-2B nmdar complexed to FAB2 non-ACTIVE2- likeelectron microscopyB, D——
7TEQCryo-EM structure of GLUN1B-2B nmdar in complex with FAB5 active conformationelectron microscopyB, D——
7TERCryo-EM structure of GLUN1B-2B nmdar in complex with FAB5 non-ACTIVE2 conformationelectron microscopyB, D——
7TESCryo-EM structure of GLUN1B-2B nmdar in complex with FAB5 in non- ACTIVE1 conformationelectron microscopyB, D——
7TETCryo-EM structure of GLUN1B-2B nmdar in complex with FAB5 in non- ACTIVE2-like conformationelectron microscopyB, D——
8G18Heterodimer of the GluN1b-GluN2B NMDA receptor amino-terminal domains bound to allosteric inhibitor…x-ray diffractionB, DNAG, YGW—
8VUYRat GluN1-2B with Fab 003-102electron microscopyB, D—15 (best 0.86)
9ARFRat GluN1-GluN2B NMDA receptor channel in complex with glycine, glutamate, and EU-1622-A, in…electron microscopyB, DNAG, GLU18 (best 0.82)
9ARGRat GluN1-GluN2B NMDA receptor channel in apo conformationelectron microscopyB, D—13 (best 0.84)
9ARHRat GluN1-GluN2B NMDA receptor channel in complex with glycineelectron microscopyB, DNAG16 (best 0.84)
9ARIRat GluN1-GluN2B NMDA receptor channel in complex with glutamateelectron microscopyB, DGLU14 (best 0.84)
Q00960AlphaFold monomer V2.0 prediction for glutamate receptor ionotropic, NMDA 2B (Q00960)———

Ligands

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · in 27 records
  • CL · Chloride ion · in 8 records
  • GLU · Glutamic acid · in 3 records
  • 1PC · 1-(phenyl-1-cyclohexyl)piperidine · in 2 records
  • 377 · Memantine · in 2 records
  • HX7 · N-{4-[(2S)-3-{butyl[2-(3,4-dichlorophenyl)ethyl]amino}-2-hydroxypropoxy]phenyl}methanesulfonamide · in 2 records
  • JC9 · (2~{S})-2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one · in 2 records
  • HXM · N-{4-[(2S)-3-{[2-(3,4-dichlorophenyl)ethyl](propan-2-yl)amino}-2-hydroxypropoxy]phenyl}methanesulfonamide · in 1 record
  • HYS · N-{4-[(2S)-3-{[2-(3,4-dichlorophenyl)ethyl]amino}-2-hydroxypropoxy]phenyl}methanesulfonamide · in 1 record
  • HYY · N-{4-[(2S)-3-{[2-(3,4-dichlorophenyl)ethyl](propyl) amino}-2-hydroxypropoxy]phenyl}methanesulfonamide · in 1 record
  • HZ4 · N-{4-[(2S)-3-{[2-(3,4-dichlorophenyl)ethyl](ethyl) amino}-2-hydroxypropoxy]phenyl}methanesulfonamide · in 1 record
  • T88 · N-{4-[(2R)-3-{butyl[2-(3,4-dichlorophenyl)ethyl]amino}-2-hydroxypropoxy]phenyl}methanesulfonamide · in 1 record
  • T97 · N-{4-[(2S)-3-{[2-(3,4-dichlorophenyl)ethyl](2-methylpropyl)amino}-2-hydroxypropoxy]phenyl}methanesulfonamide · in 1 record
  • YGW · N-(4-{3-[4-(3,4-difluorophenyl)piperazin-1-yl]-2-oxopropoxy}phenyl)methanesulfonamide · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.